Business Context and Reporting Period
This Form 8-K Current Report was filed by Neuronetics, Inc. on July 2, 2021, covering the event date of June 30, 2021. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol STIM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific corporate governance event rather than financial performance.
Material Changes
On June 30, 2021, the Compensation Committee of the Board of Directors approved an extension of the reimbursement benefit for travel and relocation assistance for Stephen Furlong, the Company's Chief Financial Officer. This benefit was originally scheduled to expire on July 22, 2021.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific executive compensation adjustment noted above.
Investor Verification Checklist
- Verify the specific terms and duration of the extended travel and relocation reimbursement for the CFO.
- Confirm the total value of the extended benefit to assess its impact on executive compensation.
- Review the original employment agreement to understand the baseline terms prior to this extension.